SAN
FRANCISCO, Aug. 1, 2024 /PRNewswire/ -- Nektar
Therapeutics (Nasdaq: NKTR) will announce its financial results for
the second quarter 2024 on Thursday, August
8, 2024, after the close of U.S.-based financial markets.
Howard Robin, President and Chief
Executive Officer, will host a conference call to review the
results beginning at 5:00 p.m. Eastern
Time/2:00 p.m. Pacific
Time.
The press release and live audio-only webcast of the conference
call can be accessed through a link that is posted on the Home Page
and Investors section of the Nektar website: http://ir.nektar.com/.
The web broadcast of the conference call will be available for
replay through September 8, 2024.
To access the conference call, please pre-register at Nektar
Earnings Call Registration. All registrants will receive dial-in
information and a PIN allowing them to access the live call.
About Nektar
Therapeutics
Nektar Therapeutics is a clinical-stage biotechnology company
focused on developing treatments that address the underlying
immunological dysfunction in autoimmune and chronic inflammatory
diseases. Nektar's lead product candidate, rezpegaldesleukin
(REZPEG, or NKTR-358), is a novel, first-in-class regulatory T cell
stimulator being evaluated in two Phase 2b clinical trials, one in atopic dermatitis and
one in alopecia areata. Our pipeline also includes a preclinical
candidate NKTR-0165, which is a bivalent tumor necrosis factor
receptor type II agonist antibody. Nektar, together with various
partners, is also evaluating NKTR-255, an investigational IL-15
receptor agonist designed to boost the immune system's natural
ability to fight cancer, in several ongoing clinical trials. Nektar
is headquartered in San Francisco,
California. For further information, visit www.nektar.com
and follow us on LinkedIn.
Contacts:
For Investors:
Vivian Wu of Nektar Therapeutics
(628) 895-0661
For Media:
David Rosen of Argot Partners
(212) 600-1902
david.rosen@argotpartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-second-quarter-2024-on-thursday-august-8-2024-after-close-of-us-based-financial-markets-302212901.html
SOURCE Nektar Therapeutics